NEULAND LABORATORIES LTD. - 524558 - Board declares Interim Dividend
Neuland Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 03, 2020, inter alia, has declared and approved payment of Interim Dividend @ Rs..2.00/- (20%) per equity share of Rs. 10/- each for the Financial Year 2020-21.The said Interim Dividend shall be paid/dispatched on November 27, 2020. NEULAND LABORATORIES LTD. - 524558 - Outcome Of Board Meeting- Un-Audited Standalone & Consolidated Financial Results And Interim Dividend For F.Y.2020-21
Outcome of Board Meeting- Un-audited Standalone & Consolidated Financial Results and Interim Dividend for F.Y.2020-21 NEULAND LABORATORIES LTD. - 524558 - Unaudited Financial Results For Quarter And Half Year Ended September 30, 2020
Unaudited Financial Results for quarter and half year ended September 30, 2020 NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Meeting Updates
We refer to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), 2015 and enclose a copy of the Q2 FY 2020-2021 Earnings Call details, for your information and records. Neuland Laboratories Ltd - 524558 - Shareholding for the Period Ended September 30, 2020
Neuland Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We are enclosing herewith the copies of newspaper publication on October 20, 2020 of the Notice of the meeting of Board of Directors scheduled to be held on Tuesday,November 3, 2020, inter-alia, to consider and approve the unaudited financial results of the Company for the quarter and half year ended September 30, 2020. This is for your information and records. NEULAND LABORATORIES LTD. - 524558 - Corporate Action- Fixes Record Date For Interim Dividend
Pursuant to Regulation 29 and 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of Board of Directors of the Company is scheduled to be held on Tuesday, November 3, 2020, inter-alia to- a.approve and take on record the unaudited financial results (standalone and consolidated) of the Company for the quarter and half year ended September 30, 2020. b.consider the recommendation of interim dividend for the financial year 2020-21, If declared, the interim dividend shall be paid to the equity shareholders of the Company whose names appear on the Register of Members of the Company or in the records of the Depositories as beneficial owners of the shares as on Wednesday, November 11, 2020 which is the Record Date fixed for the purpose. NEULAND LABORATORIES LTD. - 524558 - Corporate Action-Board to consider Dividend
Pursuant to Regulation 29 and 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of Board of Directors of the Company is scheduled to be held on Tuesday, November 3, 2020, inter-alia to- a.approve and take on record the unaudited financial results (standalone and consolidated) of the Company for the quarter and half year ended September 30, 2020. b.consider the recommendation of interim dividend for the financial year 2020-21, If declared, the interim dividend shall be paid to the equity shareholders of the Company whose names appear on the Register of Members of the Company or in the records of the Depositories as beneficial owners of the shares as on Wednesday, November 11, 2020 which is the Record Date fixed for the purpose. NEULAND LABORATORIES LTD. - 524558 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2020
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 and 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of Board of Directors of the Company is scheduled to be held on Tuesday, November 3, 2020, inter-alia to- a.approve and take on record the unaudited financial results (standalone and consolidated) of the Company for the quarter and half year ended September 30, 2020. b.consider the recommendation of interim dividend for the financial year 2020-21, if declared, the interim dividend shall be paid to the equity shareholders of the Company whose names appear on the Register of Members of the Company or in the records of the Depositories as beneficial owners of the shares as on Wednesday, November 11, 2020 which is the Record Date fixed for the purpose. NEULAND LABORATORIES LTD. - 524558 - Compliances- Certificate Under Regulation 40(9) Of SEBI(LODR) Regulations, 2015
Please find enclosed the Certificate in compliance with Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 received from a Practicing Company Secretary for the period from April 1, 2020 to September 30, 2020.